NHS Greater Glasgow and Clyde
94 capabilities
Verified Oct 2026
One of 2,018 in United Kingdom
Send one structured enquiry and we chase the reply for you. No cold email, no chasing.
Details
Laboratory Genetics, West of Scotland Genetic Services, Level 2B, Laboratory Medicine, Queen Elizabeth University Hospital, Govan Road
Glasgow G51 4TF , United Kingdom
Glasgow G51 4TF , United Kingdom
Accreditation
Active
UKAS
8290
ggc.scot.nhs.uk
Prefer to enquire through us? Send an enquiry
Accreditation Details
Accreditation Body
UKAS
Number
8290
Status
ActiveAccreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official UKAS records.
Download Scope PDFOther locations
NHS Greater Glasgow and Clyde
21 Shelley Road
NHS Greater Glasgow and Clyde
Glasgow
NHS Greater Glasgow and Clyde
Glasgow
NHS Greater Glasgow and Clyde
Paisley
NHS Greater Glasgow and Clyde
10-16 Alexandra Parade
NHS Greater Glasgow and Clyde
Glasgow
NHS Greater Glasgow and Clyde
Glasgow
NHS Greater Glasgow and Clyde
Glasgow
Test Capabilities (94)
| Standard Reference | Description | Category |
|---|---|---|
| RET | RET | Hematology |
| Sarcoma | Sarcoma | Histopathology / Cytology |
| Acute Myeloid Leukaemia (AML)/ Myelodysplastic Syndrome (MDS) | Acute Myeloid Leukaemia (AML)/ Myelodysplastic Syndrome (MDS) | Molecular Diagnostics / PCR |
| Angelman Syndrome | Angelman Syndrome | Molecular Diagnostics / PCR |
| Arthrogryposis (CE Subpanel) | Arthrogryposis (CE Subpanel) | Molecular Diagnostics / PCR |
| BRAF | BRAF | Molecular Diagnostics / PCR |
| Becker Muscular Dystrophy | Becker Muscular Dystrophy | Molecular Diagnostics / PCR |
| Beckwith-Weidemann Syndrome | Beckwith-Weidemann Syndrome | Molecular Diagnostics / PCR |
| Breast Cancer (hereditary) (NGS, 8 gene panel) | Breast Cancer (hereditary) (NGS, 8 gene panel) | Molecular Diagnostics / PCR |
| Breast and Ovarian cancer (hereditary) (NGS, 14 gene panel) | Breast and Ovarian cancer (hereditary) (NGS, 14 gene panel) | Molecular Diagnostics / PCR |
| Breast, ovarian and colorectal cancer (hereditary) (NGS, 22 gene panel) | Breast, ovarian and colorectal cancer (hereditary) (NGS, 22 gene panel) | Molecular Diagnostics / PCR |
| CADASIL | CADASIL | Molecular Diagnostics / PCR |
| CHARGE Syndrome | CHARGE Syndrome | Molecular Diagnostics / PCR |
| Chondrodysplasia Punctata (CE subpanel) | Chondrodysplasia Punctata (CE subpanel) | Molecular Diagnostics / PCR |
| Cowden Syndrome | Cowden Syndrome | Molecular Diagnostics / PCR |
| Cytogenetic and Molecular Genetic examination activities for the purpose of genetic investigations | Cytogenetic and Molecular Genetic examination activities for the purpose of genetic investigations | Molecular Diagnostics / PCR |
| Cytogenetic and Molecular Genetic investigations for the detection of germline mutations and genomic imbalance related to the following: Aneuploidy testing for common trisomies (T13, T18, T21, X and Y) | Cytogenetic and Molecular Genetic investigations for the detection of germline mutations and genomic imbalance related to the following: Aneuploidy testing for common trisomies (T13, T18, T21, X and Y) | Molecular Diagnostics / PCR |
| Cytogenetic and Molecular Genetic investigations for the detection of somatic mutations and genomic imbalance related to the following: Acute Lymphoblastic Leukaemia (ALL), including: â–ª Minimal residual disease (MRD) Paediatric ALL (including. SNP microarray) | Cytogenetic and Molecular Genetic investigations for the detection of somatic mutations and genomic imbalance related to the following: Acute Lymphoblastic Leukaemia (ALL), including: â–ª Minimal residual disease (MRD) Paediatric ALL (including. SNP microarray) | Molecular Diagnostics / PCR |
| DICER1 syndrome (CE) | DICER1 syndrome (CE) | Molecular Diagnostics / PCR |
| DiGeorge Syndrome | DiGeorge Syndrome | Molecular Diagnostics / PCR |
| Dihydropyrimidine Dehydrogenase (DPYD) | Dihydropyrimidine Dehydrogenase (DPYD) | Molecular Diagnostics / PCR |
| Dilated Cardiomyopathy | Dilated Cardiomyopathy | Molecular Diagnostics / PCR |
| Disorders of Sexual Development (NGS, 56 gene panel) | Disorders of Sexual Development (NGS, 56 gene panel) | Molecular Diagnostics / PCR |
| Duchenne Muscular Dystrophy | Duchenne Muscular Dystrophy | Molecular Diagnostics / PCR |
| Epilepsy (NGS, 104 gene panel) | Epilepsy (NGS, 104 gene panel) | Molecular Diagnostics / PCR |
| Episodic ataxia type 1 & type 2 (KCNA1 and CACNA1A) | Episodic ataxia type 1 & type 2 (KCNA1 and CACNA1A) | Molecular Diagnostics / PCR |
| FMR1-related disorders | FMR1-related disorders | Molecular Diagnostics / PCR |
| FOXL2 variant analysis | FOXL2 variant analysis | Molecular Diagnostics / PCR |
| Familial Hemiplegic Migraine (FHM) (NGS, 5 gene panel) | Familial Hemiplegic Migraine (FHM) (NGS, 5 gene panel) | Molecular Diagnostics / PCR |
| Fibrodysplasia Ossificans | Fibrodysplasia ossificans | Molecular Diagnostics / PCR |
| Fragile X syndrome | Fragile X syndrome | Molecular Diagnostics / PCR |
| Fragile X syndrome, including | Fragile X syndrome, including | Molecular Diagnostics / PCR |
| HRAS | HRAS | Molecular Diagnostics / PCR |
| KRAS | KRAS | Molecular Diagnostics / PCR |
| MLH1 promoter methylation analysis | MLH1 promoter methylation analysis | Molecular Diagnostics / PCR |
| NRAS | NRAS | Molecular Diagnostics / PCR |
| Neurodegeneration with Brain Iron accumulation (CE subpanel) | Neurodegeneration with Brain Iron accumulation (CE subpanel) | Molecular Diagnostics / PCR |
| POLE | POLE | Molecular Diagnostics / PCR |
| Rhabdomyolysis (CE Subpanel) | Rhabdomyolysis (CE Subpanel) | Molecular Diagnostics / PCR |
| SMA/dHMN (CE Subpanel) | SMA/dHMN (CE Subpanel) | Molecular Diagnostics / PCR |
| Somatic NGS, 2 gene panel (BRCA1, BRCA2) | Somatic NGS, 2 gene panel (BRCA1, BRCA2) | Molecular Diagnostics / PCR |
| TP53 | TP53 | Molecular Diagnostics / PCR |
| Y deletions | Y deletions | Molecular Diagnostics / PCR |
| Adult granulosa cell tumours | Adult granulosa cell tumours | Other |
| Brain and CNS Cancer (including Glioma) including; 1p36/1q25 and 19q13/19p13 IDH1/IDH2 and BRAF MGMT promoter methylation in Glioma | Brain and CNS Cancer (including Glioma) including; 1p36/1q25 and 19q13/19p13 IDH1/IDH2 and BRAF MGMT promoter methylation in Glioma | Other |
| Breast Cancer (acquired) | Breast Cancer (acquired) | Other |
| Chimerism Analysis | Chimerism analysis | Other |
| Chromosome investigation for inherited and congenital abnormalities | Chromosome investigation for inherited and congenital abnormalities | Other |
| Colorectal Cancer (acquired) including | Colorectal Cancer (acquired) including; | Other |
| Developmental delay, including | Developmental delay, including; | Other |
| Endometrial tumour (2 gene panel) | Endometrial tumour (2 gene panel) | Other |
| FXTAS | FXTAS | Other |
| Fertility investigations, including | Fertility investigations, including; | Other |
| Gorlin Syndrome (CE subpanel) | Gorlin Syndrome (CE subpanel) | Other |
| Haematological Malignancy, not otherwise specified | Haematological Malignancy, not otherwise specified | Other |
| Hereditary Ataxia (CE subpanel) | Hereditary Ataxia (CE subpanel) | Other |
| Hereditary Haemochromatosis (HFE related) | Hereditary Haemochromatosis (HFE related) | Other |
| Hereditary Spastic Paraplegia (CE subpanel) | Hereditary Spastic Paraplegia (CE subpanel) | Other |
| Lesch Nyhan Syndrome | Lesch Nyhan Syndrome | Other |
| Li-Fraumeni Syndrome | Li-Fraumeni Syndrome | Other |
| Limb Girdle Muscular Dystrophy 1B laminopathy | Limb Girdle Muscular Dystrophy 1B laminopathy | Other |
| Limb Girdle Muscular Dystrophy type 2I and 2R | Limb Girdle Muscular Dystrophy type 2I and 2R | Other |
| Lung Cancer, Non-Small Cell (acquired); â–ª ALK1 â–ª ROS1 â–ª EGFR â–ª BRAF KRAS | Lung Cancer, Non-Small Cell (acquired); â–ª ALK1 â–ª ROS1 â–ª EGFR â–ª BRAF KRAS | Other |
| Lymphoproliferative Neoplasms (LPN), including: â–ª Chronic Lymphocytic Leukaemia (CLL) â–ª Lymphoma â–ª Myeloma Waldenstr Ó§ ms macroglobulinaemia | Lymphoproliferative Neoplasms (LPN), including: â–ª Chronic Lymphocytic Leukaemia (CLL) â–ª Lymphoma â–ª Myeloma Waldenstr Ó§ ms macroglobulinaemia | Other |
| Malignant Melanoma (hereditary) (NGS, 5 gene panel) | Malignant Melanoma (hereditary) (NGS, 5 gene panel) | Other |
| Malignant Melanoma â–ª BRAF â–ª KIT PDGFRA | Malignant Melanoma â–ª BRAF â–ª KIT PDGFRA | Other |
| Microdeletion/Microduplication syndromes | Microdeletion/Microduplication syndromes | Other |
| Myeloproliferative Disorders (MPD), including; â–ª Chronic Myeloid Leukaemia (CML) â–ª Polycythaemia Vera â–ª Essential Thrombocythaemia Myelofibrosis | Myeloproliferative Disorders (MPD), including; â–ª Chronic Myeloid Leukaemia (CML) â–ª Polycythaemia Vera â–ª Essential Thrombocythaemia Myelofibrosis | Other |
| Myotonic Dystrophy (type 1) | Myotonic Dystrophy (type 1) | Other |
| Osteochondromas | Osteochondromas | Other |
| Osteopetrosis | Osteopetrosis | Other |
| Ovarian Cancer (hereditary) (NGS, 8 gene panel) | Ovarian Cancer (hereditary) (NGS, 8 gene panel) | Other |
| POF | POF | Other |
| Pancreatic Cancer (hereditary) 9 gene panel | Pancreatic Cancer (hereditary) 9 gene panel | Other |
| Phenylketonuria | Phenylketonuria | Other |
| Prader Willi Syndrome | Prader Willi Syndrome | Other |
| Pregnancy loss | Pregnancy loss | Other |
| Prenatal Diagnosis | Prenatal Diagnosis | Other |
| Progressiva | Progressiva | Other |
| Prostate cancer | Prostate cancer; | Other |
| Respiratory Disease (CE subpanel) | Respiratory Disease (CE subpanel) | Other |
| Rett and Rett-like Syndrome | Rett and Rett-like Syndrome | Other |
| Rhabdoid tumour | Rhabdoid tumour | Other |
| SHOX related | SHOX related | Other |
| Sex determination | Sex determination | Other |
| Short Stature, including: Turner syndrome | Short Stature, including: • Turner syndrome SHOX related | Other |
| Sickle Cell Anaemia | Sickle Cell Anaemia | Other |
| Silver Russell Syndrome | Silver Russell Syndrome | Other |
| Solid Tumours, not otherwise specified | Solid Tumours, not otherwise specified | Other |
| TERT | TERT | Other |
| Thiopurine methyltransferase (TPMT) | Thiopurine methyltransferase (TPMT) | Other |
| Thyroid tumour (6 gene panel) | Thyroid tumour (6 gene panel) | Other |
| Uveal Melanoma (acquired) | Uveal Melanoma (acquired) | Other |
| X-inactivation Studies | X-inactivation Studies | Other |
Send an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.